ITM Presents Dosimetry Data from Phase 3 COMPETE Trial Supporting Favorable Efficacy and Safety Profile with n.c.a. 177Lu-edotreotide (ITM-11) in Patients with Gastroenteropancreatic Neuroendocrine Tumors at EANM 2025 Annual Congress

Study showed targeted tumor uptake with low healthy organ exposure in broad cohort of 207 patients Supports therapeutic potential of ITM's proprietary targeted radiotherapeutic agent Abstract receives prestigious EANM Marie Curie Award, which honors outstanding research contributions in nuclear medicine Barcelona, Spain, October 8, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical […]

Solidion Technology Eliminates 3.4 Million Warrants and Derivative Liabilities in Strategic Financing Restructuring

Long-term investors Madison Bond LLC and Bayside Project LLC convert entire 3.4 million Pre-Funded Warrants into common stock to be held for at least one year, strengthening Solidion's balance sheet and shareholder alignment. Solidion Technology Inc. (“Solidion” or the “Company”) (Nasdaq: STI), an advanced battery technology solutions provider, announces a comprehensive restructuring of its previous

Tim Hortons NHL® Hockey Cards are back with an exciting new collection, plus a chance to win a trip to the 2026 Stanley Cup® Final and, for the first time, a new car!

— Highlights in this year's set include hockey cards autographed by Sidney Crosby and Nathan MacKinnon, a signed Timbits® card featuring Logan Stankoven, a 3D lenticular card commemorating the 4 Nations Face-Off™, and more golden prize cards like a VIP Trip to the 2026 Stanley Cup® Final, and for the first time, collectors have a

Cenovus announces amended agreement with increased price to acquire MEG Energy and provides update on third-quarter operating results

Cenovus announces amended agreement with increased price to acquire MEG Energy and provides update on third-quarter operating results GlobeNewswire October 08, 2025 CALGARY, Alberta, Oct. 08, 2025 (GLOBE NEWSWIRE) — Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) today announced that it has entered into an amending agreement in respect of the arrangement agreement dated August

Single-Paycheck Panic: 67% of Gen Z Say “Income Stacking” is Essential for Financial Security

Single-Paycheck Panic: 67% of Gen Z Say “Income Stacking” is Essential for Financial Security One Job? In This Economy? Fiverr's Next Gen of Work research finds 54% of Gen Z and Gen Alpha believe traditional employment will become obsolete, with 42% embracing a '9-whenever' mindset GlobeNewswire October 08, 2025 NEW YORK, Oct. 08, 2025 (GLOBE

RecycLiCo Retains Rain City Industrial for Design and Construction of Innovation Lab

RecycLiCo Retains Rain City Industrial for Design and Construction of Innovation Lab GlobeNewswire October 08, 2025 DELTA, British Columbia, Oct. 08, 2025 (GLOBE NEWSWIRE) — RecycLiCo Battery Materials Inc. (“RecycLiCo” or the “Company”) (TSX.V:AMY | OTCQB:AMYZF | FSE:ID4), a critical mineral refining and lithium-ion battery upcycling company, is pleased to announce that it has contracted

Dr. Heather Pressler of BlueHuki Named First Annual 2025 Mighty MilSpouse Of The Year

Dr. Heather Pressler of BlueHuki Named First Annual 2025 Mighty MilSpouse Of The Year GlobeNewswire October 08, 2025 FALLS CHURCH, Va., Oct. 08, 2025 (GLOBE NEWSWIRE) — Dr. Heather Pressler, founder and CEO of BlueHuki marketing agency, was awarded the very first Mighty MilSpouse of the Year at the 2025 annual Military Influencer Conference (MIC).

Largest On-Chain Economy is Being Built in Africa with $5.5B in Real-World Assets by Global Settlement Network and Diacente

Largest On-Chain Economy is Being Built in Africa with $5.5B in Real-World Assets by Global Settlement Network and Diacente GlobeNewswire October 08, 2025 Largest On-Chain Economy is Being Built in Africa with $5.5B in Real-World Assets by Global Settlement Network and Diacente The partnership will bring $5.5 billion worth of real-world infrastructure assets on-chain, spanning

ITM Presents Dosimetry Data from Phase 3 COMPETE Trial Supporting Favorable Efficacy and Safety Profile with n.c.a. 177Lu-edotreotide (ITM-11) in Patients with Gastroenteropancreatic Neuroendocrine Tumors at EANM 2025 Annual Congress

ITM Presents Dosimetry Data from Phase 3 COMPETE Trial Supporting Favorable Efficacy and Safety Profile with n.c.a. 177Lu-edotreotide (ITM-11) in Patients with Gastroenteropancreatic Neuroendocrine Tumors at EANM 2025 Annual Congress GlobeNewswire October 08, 2025 Study showed targeted tumor uptake with low healthy organ exposure in broad cohort of 207 patients Supports therapeutic potential of ITM's

Immuron Submits IMM-529 IND to FDA

Immuron Submits IMM-529 IND to FDA GlobeNewswire October 08, 2025 Key Points Immuron submits Investigational new drug (IND) application to FDA for clinical development of IMM-529 as product to specifically prevent or treat Clostridioides difficile infection (CDI) Previous clinical trial data on IMM-529 provides support for continued development of IMM-529 MELBOURNE, Australia, Oct. 08, 2025

Scroll to Top